Immunization with DCs loaded exvivo with tumor Ag, is a promising strategy for inducing efficient antitumor immunity [4] that has been successfully used to vaccinate mice and to activate CTL responses in preclinical trials [5]–[8]. This evidence concerns the gene RENBP and neoplasm.